B. Lo Et Al. , "AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.," Science (New York, N.Y.) , vol.349, no.6246, pp.436-40, 2015
Lo, B. Et Al. 2015. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.. Science (New York, N.Y.) , vol.349, no.6246 , 436-40.
Lo, B., Zhang, K., Lu, W., Zheng, L., Zhang, Q., Kanellopoulou, C., ... Zhang, Y.(2015). AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.. Science (New York, N.Y.) , vol.349, no.6246, 436-40.
Lo, Bernice Et Al. "AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.," Science (New York, N.Y.) , vol.349, no.6246, 436-40, 2015
Lo, Bernice Et Al. "AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.." Science (New York, N.Y.) , vol.349, no.6246, pp.436-40, 2015
Lo, B. Et Al. (2015) . "AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.." Science (New York, N.Y.) , vol.349, no.6246, pp.436-40.
@article{article, author={Bernice Lo Et Al. }, title={AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.}, journal={Science (New York, N.Y.)}, year=2015, pages={436-40} }